Skip to main content
Livermore
Livermore
ZHEN

Sittner & Nelson, LLC

SEC CIK
0001846138
Latest filing
Aug 7, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Sittner & Nelson, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
4,801
Value
$261.8K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of CRSP by Sittner & Nelson, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,801$261.8K0.1%−250−4.9%ReducedHolders
Q1 20265,051$240.3K0.1%−140−2.7%ReducedHolders
Q4 20255,191$253.0K0.1%+140+2.8%AddedHolders
Q3 20255,051$327.4K0.1%+81+1.6%AddedHolders
Q2 20254,970$241.7K0.1%+580+13.2%AddedHolders
Q1 20254,390$149.4K0.1%00.0%UnchangedHolders
Q4 20244,390$172.8K0.1%+653+17.5%AddedHolders
Q3 20243,737$175.6K0.1%+190+5.4%AddedHolders
Q2 20243,547$191.6K0.1%−300−7.8%ReducedHolders
Q1 20243,847$262.2K0.1%+250+7.0%AddedHolders
Q4 20233,597$225.2K0.1%−90−2.4%ReducedHolders
Q3 20233,687$167.4K0.1%+150+4.2%AddedHolders
Q2 20233,537$198.6K0.1%00.0%UnchangedHolders
Q1 20233,537$160.0K0.1%+130+3.8%AddedHolders
Q4 20223,407$138.5K0.1%−20−0.6%ReducedHolders
Q3 20223,427$224.0K0.2%00.0%UnchangedHolders
Q2 20223,427$208.0K0.1%00.0%UnchangedHolders
Q1 20223,427$215.0K0.1%+700+25.7%AddedHolders
Q4 20212,727$207.0K0.1%+210+8.3%AddedHolders
Q3 20212,517$282.0K0.2%+887+54.4%AddedHolders
Q2 20211,630$264.0K0.2%+430+35.8%AddedHolders
Q1 20211,200$146.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.